MRVL vs UTHR · P/E 100, rev $5.16B vs P/E 20, rev $1.56B
Marvell Technology Group Ltd (MRVL) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
MRVL currently screens at market cap $253.51B and trailing P/E 99.8. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the MRVL and UTHR stock pages for the full models.
Not investment advice.